Related Experiment Video
Updated: Aug 24, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
p53 can inhibit cell proliferation through caspase-mediated cleavage of ERK2/MAPK
A Marchetti1, B Cecchinelli, M D'Angelo
1Molecular Oncogenesis Laboratory, Department of Experimental Oncology, Regina Elena Cancer Institute, 00158 Rome, Italy.
Abstract:
Stimulation of the Ras/MAPK cascade can either activate p53 and promote replicative senescence and apoptosis, or degrade p53 and promote cell survival. Here we show that p53 can directly counteract the Ras/MAPK signaling by inactivating ERK2/MAPK. This inactivation is due to a caspase cleavage of the ERK2 protein and contributes to p53-mediated growth arrest. We found that in Ras-transformed cells, growth arrest induced by p53, but not p21(Waf1), is associated with a strong reduction in ERK2 activity, phosphorylation, and protein half-life, and with the appearance of caspase activity. Likewise, DNA damage-induced cell cycle arrest correlates with p53-dependent ERK2 downregulation and caspase activation. Furthermore, caspase inhibitors or expression of a caspase-resistant ERK2 mutant interfere with ERK2 cleavage and restore proliferation in the presence of p53 activation, indicating that caspase-mediated ERK2 degradation contributes to p53-induced growth arrest. These findings strongly point to ERK2 as a novel p53 target in growth suppression.
Insights
The tumor suppressor p53 directly inhibits Ras/MAPK signaling by inactivating ERK2, a process mediated by caspases. This mechanism contributes to p53-driven growth arrest and identifies ERK2 as a novel p53 target.
Area of Science:
- Molecular Biology
- Cellular Signaling
- Cancer Research
Background:
- The Ras/MAPK pathway plays a dual role in cell fate, influencing p53 activity, senescence, apoptosis, and survival.
- Understanding how p53 interacts with and regulates key signaling pathways like Ras/MAPK is crucial for cancer therapy.
Purpose of the Study:
- To investigate the direct mechanism by which p53 counteracts Ras/MAPK signaling.
- To elucidate the role of ERK2 inactivation in p53-mediated growth suppression.
Main Methods:
- Analysis of Ras-transformed cells and DNA damage-induced cell cycle arrest models.
- Assays for ERK2 activity, phosphorylation, and protein half-life.
- Utilized caspase inhibitors and caspase-resistant ERK2 mutants.
Main Results:
- p53 directly inactivates ERK2/MAPK activity through caspase-mediated cleavage.
- p53-induced growth arrest correlates with reduced ERK2 activity, phosphorylation, and half-life, alongside increased caspase activity.
- Inhibition of caspase activity or expression of a resistant ERK2 mutant abrogates p53-mediated growth arrest.
Conclusions:
- Caspase-mediated degradation of ERK2 is a key mechanism contributing to p53-induced growth arrest.
- ERK2 represents a novel molecular target of p53 in the context of tumor suppressor functions.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Abnormal Proliferation
Negative Regulator Molecules
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Inhibition of Cdk Activity